Circuit-specific gene therapy reverses core symptoms in a primate Parkinson’s disease model
An AAV-based circuit modulation approach that consists of a designer retrograde AAV capsid, a medium spiny neuron-enriched promoter, and a selected chemogenetic effector specifically modulates direct...